Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery

Clinical Therapeutics

Volumn 31, Issue 3, 2009, Pages 527-541

  Oifa, Stanislav ^a   Sydoruk, Tatiana ^a   White, Ian ^a   Ekstein, Margaret P ^a   Marouani, Nissim ^a   Chazan, Shoshana ^a   Skornick, Yehuda ^a   Weinbroum, Avi A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

bolus; buprenorphine; infusion; IV PCA; morphine; pain; postoperative

Indexed keywords

BUPRENORPHINE; DICLOFENAC; GRANISETRON; METOCLOPRAMIDE; MORPHINE; PROMETHAZINE;

ABDOMINAL SURGERY; ADULT; AGED; AGITATION; ARTERIAL OXYGEN TENSION; ARTICLE; BREATHING RATE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUPRENORPHINE; DICLOFENAC; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GASTRECTOMY; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PANCREATECTOMY; PATIENT SATISFACTION; PROSPECTIVE STUDIES; RESPIRATION; TIME FACTORS; TREATMENT OUTCOME; WAKEFULNESS; YOUNG ADULT;

EID: 64849092311     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.03.018     Document Type: Article

References (51)

1. Kastanias P., Snaith K.E., and Robinson S. Patient-controlled oral analgesia: A low-tech solution in a high-tech world. Pain Manag Nurs 7 (2006) 126-132
2. Andersen G., Christrup L., and Sjøgren P. Relationships among morphine metabolism, pain and side effects during longterm treatment: An update. J Pain Symptom Manage 25 (2003) 74-91
3. Huang P., Kehner G.B., Cowan A., and Liu-Chen L.Y. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 297 (2001) 688-695
4. Kamei J., Saitoh A., Suzuki T., et al. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors. Life Sci 56 (1995) PL285-PL290
5. Leander J.D. Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice. Eur J Pharmacol 151 (1988) 457-461
6. Yamamoto T., Shono K., and Tanabe S. Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test. J Pharmacol Exp Ther 318 (2006) 206-213
7. Kögel B., Christoph T., Strassburger W., and Friderichs E. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Eur J Pain 9 (2005) 599-611
8. Boas R.A., and Villiger J.W. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 57 (1985) 192-196
9. Cowan A. Update on the general pharmacology of buprenorphine. In: Cowan A., and Lewis J.W. (Eds). Buprenorphine: combating Drug Abuse with a Unique Opioid (1995), Wiley-Liss, New York, NY 31-47
10. Reisine T., and Pasternak G. Opioid analgesics and antagonists. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed (1996), McGraw-Hill, New York, NY 521-555
11. Chang K.Y., Chang W.K., Chang W.L., et al. Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion-a prospective randomized clinical trial. Acta Anaesthesiol Taiwan 44 (2006) 153-159
12. Information for health professionals. Data sheet. Temgesic injection (2004), Reckitt Benckiser Healthcare Ltd, Hull, UK
13. Walker E.A., and Young A.M. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology (Berl) 154 (2001) 131-142
14. Mizoguchi H., Spaulding A., Leitermann R., et al. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse. J Pharmacol Exp Ther 306 (2003) 394-400
15. Morgan D., Cook C.D., and Picker M.J. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor. J Pharmacol Exp Ther 289 (1999) 965-975
16. Morgan D., Cook C.D., Smith M.A., and Picker M.J. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity. Anesth Analg 88 (1999) 407-413
17. Thomsen A.B., Becker N., and Eriksen J. Opioid rotation in chronic nonmalignant pain patients. A retrospective study. Acta Anaesthesiol Scand 43 (1999) 918-923
18. Beltrutti D., Niv D., Ben-Abraham R., et al. Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans. J Clin Anesth 14 (2002) 441-446
19. Beltrutti D., and Niv D. Pain relief after simultaneous administration of intravenous buprenorphine and intrathecal morphine in terminally ill patients: A report of two cases. Pain Clin 12 (2000) 121-123
20. Walsh S.L., Preston K.L., Stitzer M.L., et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 55 (1994) 569-580
21. Torres L.M., Collado F., Almarcha J.M., et al. Treatment of postoperative pain with intravenous PCA system. Comparison with morphine, metamizole, and buprenorphine [in Spanish]. Rev Esp Anestesiol Reanim 40 (1993) 181-184
22. Cowan A., Friedrichs E., Strassburger W., and Raffa R.B. Basic pharmacology of buprenorphine. In: Budd K., and Raffa R.B. (Eds). Buprenorphine-The Unique Opioid Analgesic (2005), Georg Thieme Verlag, Stuttgart, Germany 3-21
23. Mégarbane B., Hreiche R., Pirnay S., et al. Does high-dose buprenorphine cause respiratory depression? possible mechanisms and therapeutic consequences. Toxicol Rev 25 (2006) 79-85
24. Lehmann K.A., and Gördes B. Postoperative on-demand analgesia with buprenorphine [in German]. Anaesthesist 37 (1988) 65-70
25. Walsh S.L., Preston K.L., Bigelow G.E., and Stitzer M.L. Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 274 (1995) 361-372
26. Swinscow T.D., and Campbell M.J. Statistics at Square One. 10th ed (2002), BMJ Publishing Group, London, UK
27. Weinbroum A.A., Bender B., Bickels J., et al. Preoperative and postoperative dextromethorphan provides sustained reduction in postoperative pain and patient-controlled epidural analgesia requirement: A randomized, placebo-controlled, double-blind study in lower-body bone malignancy-operated patients. Cancer 97 (2003) 2334-2340
28. Rothman R.B., Ni Q., and Xu H. Buprenorphine: A review of the binding literature. In: Cowan A., and Lewis J.W. (Eds). Buprenorphine: combating Drug Abuse with a Unique Opioid (1995), Wiley-Liss, New York, NY 19-30
29. Vedig A.E., Gibbs J.M., Rutten A.J., and Ilsley A.H. The effect of buprenorphine on the analgesic and respiratory depressant effects of pethidine: A preliminary study. Pain 34 (1988) 253-259
30. Dingus D.J., Sherman J.C., Rogers D.A., et al. Buprenorphine versus morphine for patient-controlled analgesia after cholecystectomy. Surg Gynecol Obstet 177 (1993) 1-6
31. Giannotti C., and Lazzari A. Postoperative analgesia with PCA in 300 patients. A comparison of four therapeutic regimes. [in Italian] [published correction appears in Minerva Anestesiol. 1998;64:XXV]. Minerva Anestesiol 64 (1998) 89-97
32. Lejus C., Blanloeil Y., François T., et al. Post-operative intravenous continuous analgesia: comparison of buprenorphine, fentanyl and nalbuphine. Eur J Anaesthesiol 13 (1996) 57-65
33. Pugh G.C., Drummond G.B., Elton R.A., and Macintyre C.C. Constant i.v. infusions of nalbuphine or buprenorphine for pain after abdominal surgery. Br J Anaesth 59 (1987) 1364-1374
34. Lehmann K.A., Grond S., Freier J., and Zech D. Postoperative pain management and respiratory depression after thoracotomy: A comparison of intramuscular piritramide and intravenous patient-controlled analgesia using fentanyl or buprenorphine. J Clin Anesth 3 (1991) 194-201
35. Zanette G., Manani G., Giusti F., et al. Respiratory depression following administration of low dose buprenorphine as postoperative analgesic after fentanyl balanced anaesthesia. Paediatr Anaesth 6 (1996) 419-422
36. Weinbroum A.A. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 96 (2003) 789-795
37. Walker E.A., Zernig G., and Woods J.H. Buprenorphine antagonism of mu-opioids in the rhesus monkey tailwithdrawal procedure. J Pharmacol Exp Ther 273 (1995) 1345-1352
38. Cowan A., Lewis J.W., and Macfarlane I.R. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60 (1977) 537-545
39. Dahan A., Yassen A., Bijl H., et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth 94 (2005) 825-834
40. Basdevant C., Spérandio M., Gauthé-Feissel M., et al. Risk evaluation of oxygen desaturation after buprenorphine or morphine administration during the early postoperative period [in French]. Ann Fr Anesth Reanim 13 (1994) 285-288
41. Budd K. High dose buprenorphine for postoperative analgesia. Anaesthesia 36 (1981) 900-903
42. Maunuksela E.L., Korpela R., and Olkkola K.T. Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children. Br J Anaesth 60 (1988) 48-55
43. Dahan A., Yassen A., Romberg R., et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 96 (2006) 627-632
44. Streedbeck N.W. Beta-adrenoceptor blockade and anesthesia. AANA J 56 (1988) 334-337
45. Khan F.A., Memon G.A., and Kamal R.S. Effect of route of buprenorphine on recovery and postoperative analgesic requirement in paediatric patients. Paediatr Anaesth 12 (2002) 786-790
46. Glynn C.J. Buprenorphine and acute pain. In: Budd K., and Raffa R.B. (Eds). Buprenorphine-The Unique Opioid Analgesic: Pharmacology and Clinical Application (2005), Thieme-Verlag, New York, NY 41-51
47. Pickworth W.B., Johnson R.E., Holicky B.A., and Cone E.J. Subjective and physiologic effects of intravenous buprenorphine in humans. Clin Pharmacol Ther 53 (1993) 570-576
48. Capogna G., Celleno D., Sebastiani M., et al. Continuous intravenous infusion with patient-controlled anesthesia for postoperative analgesia in cesarean section: morphine versus buprenorphine [in Italian]. Minerva Anestesiol 55 (1989) 33-38
49. Johnson R.E., and Strain E.C. Other medications for opioid dependence. In: Strain E.C., and Stitzer M.L. (Eds). Methadone Treatment for Opioid Dependence (1999), Johns Hopkins University Press, Baltimore, Md 281-321
50. Rothman R.B., Gorelick D.A., Heishman S.J., et al. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. J Subst Abuse Treat 18 (2000) 277-281
51. Twycross R.G. Opioids. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain (1999), Churchill Livingstone, London, UK 1187-1214